Air Pollution Reduction in the Elderly and Cardiovascular and Cognitive Outcomes (ELIFA)
Air Pollution Reduction in the Elderly and Cardiovascular and Cognitive Outcomes, an Intervention Study
Short-term and chronic exposure to ambient levels of particulate matter (PM) is associated with increased morbidity and mortality related to respiratory and cardiovascular disease. Proposed biological pathways imply that particle-induced inflammation plays a role in activating the vascular endothelium and altering vascular function. Accumulating evidence suggests that outdoor air pollution has a significant impact on central nervous system health and disease and living in conditions with elevated air pollution has been linked to decreased cognitive function.
Only recently was shown that reductions in ambient levels of PM2.5 were associated with improvements in life expectancy. However, studies of the beneficial effects of improved indoor air quality on healthy humans are lacking.
With this project the investigators intend to study the effects of rooms with clean air in the elderly with the emphasis on cardiovascular and cognitive function. The investigators hypothesise that by means of air cleaning, controlled and reduced exposure has a positive effect on cardiovascular parameters such as blood pressure, heart rate variability, macro- and microcirculation and on neurobehavioral function. The investigators substantiate these outcomes with potential mechanisms of action at the transcript and epigenetic level as with hematological parameters, markers of inflammation, lipid and protein oxidation products and mitochondrial DNA damage. To achieve these goals there is a specific need to study the elderly, as they appear to have elevated susceptibility and have the largest attributable risk related to indoor PM, as they spend more time indoors. Suited concepts for study location are elderly homes ("service flats") and retirement homes.
The "ELiFA"-cohort stands for Elderly Living in Filtered Air consisting of an intervention study during 2-week periods of a pre-purification (baseline), active purification and a post purification period.
調査の概要
詳細な説明
Study Population and Design
Persons living in ''service flats'' or retirement homes are healthy elderly who respectively live semi-independently or dependently. The elderly homes will be located in Flanders, Belgium. Persons are included if they are 65 years or older, not bedridden, non- smoker and able to give informed consent. This selection is made on the basis of the mental state of candidate participants, this primary selection is based on the advice of the directors or head nurses of the elderly homes.
A documented minimental state examination (MMSE) will be performed and the participation of the candidates will depend on a priori determined criteria (score 23) and the ability of the possible participant to perform the NES tests (cognitive test), done a priori of enrolment. The project design is an intervention study of in total 6 weeks, starting with a baseline pre-purification period, a 2-week active purification period and a 2-week post purification period. Each participant is his/her own control, excluding confounding by factors that are stable within an individual over time but vary between participants.
The device (GENANO tubes, GENANO Benelux; Heusen-Zolder, België) is placed in the living room of each apartment during the study period. These kinds of air purification devices are used in medical settings (cleanrooms, medical practice) and give us the opportunity to create a well-controlled experimental real life setting.
Ultra fine particle (UFP) (Aerasense, Philips), PM10-2.5 and total suspended particulates (TSP) (Aerocet, MetOne) are monitored. Blood and urine are sampled every week in the morning at the same hour per participant to avoid problems due to diurnal variation. The participants will be asked to fill in a questionnaire. For the duration of the study, the investigators ask the participants to keep their windows closed.
Primary Endpoints The primary endpoints focus on changes in the cardiovascular en neurobiological function.
2.1 Cardiovascular function. The cardiovascular measurements are conducted non-invasively and are wide ranging in order to comprehensively study these effects.
2.1.1. Microvasculature: After pupillary dilation, digital images of both the retinas are obtained using a digital retinal camera (Canon CR-2 Digital Retinal Camera).
2.1.2. Macro vasculature: The distensibility and intermedia thickness of the carotid artery are measured by echo-graphical imaging with the esaote MY LAB ™ ONE mobil device.
2.1.3.Heart rate variability: With a mobile ECG sensor (Biopatch, Zephyr) the heart rate variability (HRV) is continuously monitored for several 24h periods during the 3 phases of the study.
2.1.4. Blood pressure: Using Stabil-O-Graph devices the blood pressure is determined 5 consecutive times for every time point.
2.2 Cognitive function The investigators assess the neurobehavioral function with the Neurobehavioral Evaluation System (NES-3). Neurobehavioral Evaluation System (NES) is a computerised battery of tests developed to study the neurological effects of an exposure to environmental agents. The investigators use the digit span test, the continuous performance and the Stroop test.
- Secondary Endpoints The investigators delineate these outcomes with secondary endpoints to find potential mechanisms of action at the transcript and epigenetic level as with on haematological parameters, markers of inflammation and lipid and protein oxidation products and mitochondrial DNA damage.
3.1. Transcriptomics and Epigenetics The investigators study underlying mechanisms either by full transcriptome analysis and gene specific transcription patterns as well as by specific hypothesis driven microRNA studies. Epigenetic profiles are studied by gene specific methylation sequencing.
3.2. Haematological measurements, markers of inflammation, and oxidative stress.
The investigators measure hemoglobin, red blood cells, fibrinogen, platelets, coagulation factors (II + VII + X), IL-6 and urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxo-dG).
3.3. Mitochondrial DNA damage The investigators measure the mitochondrial DNA content relative to nuclear DNA by means of qPCR, which is a measure of DNA damage and can give an indication of the need to repair mitochondrial DNA damage. As this parameter is an early sensor of DNA-damage these samples will be collected from the whole blood tubes.
研究の種類
入学 (予想される)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Tim S Nawrot, PhD
- 電話番号:+3211268382
- メール:tim.nawrot@uhasselt.be
研究連絡先のバックアップ
- 名前:Michelle Plusquin, PhD
- 電話番号:+32486495954
- メール:michelle.plusquin@uhasselt.be
研究場所
-
-
Limburg
-
Scherpenheuvel、Limburg、ベルギー、3271
- 募集
- Rusthuis Honighsdries
-
コンタクト:
- Harry Roels, PhD
- メール:harry.roels@uhasselt.be
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- The selection is made on the basis of the mental state of candidate participants, this primary selection is based on the advice of the directors or head nurses of the elderly homes, as in the investigators' previous studies (Jacobs et al., 2012).
- A documented minimental state examination (MMSE) will be performed and the participation of the candidates will depend on a priori determined criteria (score of 23) and the ability of the possible participant to perform the NES tests (cognitive test), done a priori of enrolment.
Exclusion Criteria:
- 65 years or older
- Non- smoker
- Not bed-ridden
- Able to give informed consent.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:基礎科学
- 割り当て:なし
- 介入モデル:単一グループの割り当て
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
---|---|
他の:Air filtering in the living room
GENANO tubes, GENANO Benelux; Heusen-Zolder, Belgium
|
The air filter will be placed in the living room of the elderly people.
The efficiency of this device has been tested and a drop of ultrafine particles of more then 70 % is achieved.
他の名前:
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
Cognitive endpoints as assessed by the Neurobehavioral Evaluation System (NES-3)
時間枠:The cognitive outcome is performed weekly during the 6 week period, changes from baseline measurement are studied
|
The investigators assess the neurobehavioral function with the Neurobehavioral Evaluation System (NES-3) (Baker et al., 1985, Kiciński et al., 2012).
Neurobehavioral Evaluation System (NES) is a computerized battery of tests developed to study the neurological effects of an exposure to environmental agents.
They use the digit span test, the continuous performance and the Stroop test.
|
The cognitive outcome is performed weekly during the 6 week period, changes from baseline measurement are studied
|
Cardiovascular endpoint: Microvasculature
時間枠:The cardiovascular outcome is performed weekly during the 6 week period, changes from baseline measurement are studied
|
Microvasculature imaging is performed to establish changes in cardiovascular status due to living in filtered air.
Microvasculature is measured by taking a digital picture of the retina vasculature using a digital retinal camera (Canon CR-2 Digital Retinal Camera), the diameter of the retinal vasculature is determined.
|
The cardiovascular outcome is performed weekly during the 6 week period, changes from baseline measurement are studied
|
Cardiovascular endpoint: Macro vasculature (carotid intima media thickness)
時間枠:The cardiovascular outcome is performed weekly during the 6 week period, changes from baseline measurement are studied
|
Macro vasculature is determined to establish changes in cardiovascular status due to living in filtered air.
Macro vasculature is determined by measuring the carotid intima media thickness using the esaote MY LAB ™ ONE mobil device.
|
The cardiovascular outcome is performed weekly during the 6 week period, changes from baseline measurement are studied
|
Cardiovascular endpoint: Heart rate variability (24h)
時間枠:The cardiovascular outcome is performed weekly during the 6 week period, changes from baseline measurement are studied
|
Heart rate variability (hrv) measurements are performed to establish changes in cardiovascular status due to living in filtered air.
Hrv (24h) is measured using a Zephyr biopatch attached to the chest.
|
The cardiovascular outcome is performed weekly during the 6 week period, changes from baseline measurement are studied
|
Cardiovascular endpoint: Blood pressure
時間枠:The cardiovascular outcome is performed weekly during the 6 week period, changes from baseline measurement are studied
|
Blood pressure is measured to establish changes in cardiovascular status due to living in filtered air.
Using Stabil-O-Graph devices the blood pressure is determined 5 consecutive times for every time point.
|
The cardiovascular outcome is performed weekly during the 6 week period, changes from baseline measurement are studied
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
Underlying mechanisms at the molecular level: Transcriptomics and Epigenetics
時間枠:Weekly during the 6 week period, changes from baseline measurement are studied
|
Underlying mechanisms are studied either by full transcriptome analysis and gene specific transcription patterns as well as by specific hypothesis driven microRNA studies.
Epigenetic profiles are studied by gene specific methylation sequencing.
This is a composite outcome studying the processes influencing gene-expression.
|
Weekly during the 6 week period, changes from baseline measurement are studied
|
Underlying mechanisms at the molecular level: Markers of inflammation, and oxidative stress and haematological markers
時間枠:Weekly during the 6 week period, changes from baseline measurement are studied
|
The investigators measure hemoglobin, red blood cells, fibrinogen, platelets, coagulation factors (II + VII + X), IL-6 and urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxo-dG).
This is a composite outcome studying inflammation and oxidative stress, 2 processes possibly underlying the health effects of air pollutants.
|
Weekly during the 6 week period, changes from baseline measurement are studied
|
Underlying mechanisms at the molecular level: Mitochondrial DNA damage
時間枠:Weekly during the 6 week period, changes from baseline measurement are studied
|
The mitochondrial DNA content relative to nuclear DNA is determined by qPCR , which is a measure of DNA damage and can give an indication of the need to repair mitochondrial DNA damage.
|
Weekly during the 6 week period, changes from baseline measurement are studied
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Tim S Nawrot, PhD、Hasselt University
研究記録日
主要日程の研究
研究開始
一次修了 (予想される)
研究の完了 (予想される)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (見積もり)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
- ELIFA_TN
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
Air filteringの臨床試験
-
Ann & Robert H Lurie Children's Hospital of Chicago完了
-
Protalixわからない
-
Massachusetts General HospitalUnited States Agency for International Development (USAID); Grand Challenges Canada積極的、募集していない周産期仮死 | 窒息新生児 | 出生時窒息アメリカ
-
AlyatecMedicom完了